Haleon: Too Vanilla For My Liking - I See Why GSK & Pfizer Wanted Out
Haleon was spun off from GSK amid investor pressure, showing steady growth but facing debt concerns. See more about HLN stock ...
Livewire Markets2d
How this healthcare stock exemplifies steady compounding
Despite pressure on consumer spending, consumers prioritise trusted brands for their health-related needs and Haleon is a ...
Haleon misses Q3 forecasts on stronger pound
Haleon missed third-quarter revenue and profit expectations on Thursday, hit by a stronger pound and lower sales of its ...
Sensodyne-maker Haleon posts unexpected drop in revenue on weak demand for its painkiller
(Reuters) -Haleon posted an unexpected drop in third-quarter revenue on Thursday, hurt by a weak demand for its painkiller in ...
Haleon Backs Guidance Despite Revenue, Profit Miss
Haleon--which houses Sensodyne toothpaste and Aquafresh mouthwash as well as over-the-counter medicines Panadol and Advil--posted organic revenue growth of 6.1%. The company had guided revenue growth ...
Haleon hampered by currency headwinds as shares slip
Currency fluctuations meant Haleon saw year-on-year reported revenue slip 0.6% to £2.78bn in the third quarter, below ...
Haleon misses Q3 forecasts on weak Panadol sales, stronger pound
By Yamini Kalia (Reuters) -Haleon missed third-quarter revenue and profit expectations on Thursday, partly hurt by a stronger ...
Is the Haleon share price in trouble ahead of earnings?
Haleon (HLN) share price has retreated in the past few weeks, erasing some of the gains made earlier this year. Its London ...